Akebia Therapeutics, Inc. (AKBA) — 分析师展望 / 分析师共识目标价为. 基于 11 位分析师评级, 共识为 看涨 — 7 买入, 3 持有, 1 卖出.
分析师共识目标价为 $4.00, 上涨空间为 158.1% 相对于当前价格 $1.55.
分析师预估 每股收益(EPS)为 $-0.31 和 营收为 $0.15B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.33 vs 预期 $-0.31 (不及预期 -8%). 2025: 实际 $-0.02 vs 预期 $0.00 (不及预期 -754.1%). 分析师准确度: 39%.
AKBA 股票 — 12个月价格预测
$4.00
▲ +158.06% 上涨空间
平均目标价
Based on 11 Wall Street analysts offering 12-month price targets for Akebia Therapeutics, Inc., the price target is $4.00.
平均目标价相对最新价格 $1.55 变动 +158.06%。
AKBA 分析师评级
Buy
基于过去3个月内 11 位分析师对 Akebia Therapeutics, Inc. 的评级
EPS 预测 — AKBA
39%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.33
vs Est –$0.31
▼ 7.4% off
2025
Actual –$0.02
vs Est $0.00
▼ 115.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — AKBA
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.160B
vs Est $0.151B
▲ 5.7% off
2025
Actual $0.236B
vs Est $0.229B
▲ 2.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
